A Quantitative Systems Pharmacology Model Describing the Cellular Kinetic-Pharmacodynamic Relationship for a Live Biotherapeutic Product to Support Microbiome Drug Development.

MLA

Renardy, Marissa, et al. “A Quantitative Systems Pharmacology Model Describing the Cellular Kinetic-Pharmacodynamic Relationship for a Live Biotherapeutic Product to Support Microbiome Drug Development.” Clinical Pharmacology and Therapeutics, vol. 114, no. 3, Sept. 2023, pp. 633–43. EBSCOhost, https://doi.org/10.1002/cpt.2952.

APA

Renardy, M., Prokopienko, A. J., Maxwell, J. R., Flusberg, D. A., Makaryan, S., Selimkhanov, J., Vakilynejad, M., Subramanian, K., & Wille, L. (2023). A Quantitative Systems Pharmacology Model Describing the Cellular Kinetic-Pharmacodynamic Relationship for a Live Biotherapeutic Product to Support Microbiome Drug Development. Clinical Pharmacology and Therapeutics, 114(3), 633–643. https://doi.org/10.1002/cpt.2952

Chicago

Renardy, Marissa, Alexander J Prokopienko, Joseph R Maxwell, Deborah A Flusberg, Sahak Makaryan, Jangir Selimkhanov, Majid Vakilynejad, Kalyanasundaram Subramanian, and Lucia Wille. 2023. “A Quantitative Systems Pharmacology Model Describing the Cellular Kinetic-Pharmacodynamic Relationship for a Live Biotherapeutic Product to Support Microbiome Drug Development.” Clinical Pharmacology and Therapeutics 114 (3): 633–43. doi:10.1002/cpt.2952.